# KSCPT 2016 Fall

- 대한임상약리학회 2016년도 추계학술대회
- 일 시 : 2016년 11월 17일(목)~18일(금)
- 장 소 : 전북대병원 임상연구지원센터 2층 새만금홀

## First Day

### A new target for HIV-1 / AIDS drug 
- speaker: 유지창 ((주)에빅스젠 / 가톨릭의대)
- integrase inhibitor (4th generation)
- 개발중인 치료제
    - NtRTI, NNRTI, INSTI etc
    - Targeting packaging.
- Nucleocapsid (NC) protein - important for RNA packaging
- Tox, body disposition
- Traditional - Zinc chelator/ejector
- Brand-new - NC and viral RNA attachment inhibition -> packaging and utilitzation
- First-in-class
- Phase I, SAD
- Question: 동물실험? Answer: Not done
- Quesiton: Screening을 어떤식으로 했는가? Answer: 직접 개발함

### New drug target for osteoporosis: GPR120 
- speaker: 김현주 (경북의대)
- 골다공증
- RANKL (OB) - RANK(OC) - Homeostasis
- Reduced estrogen (menopause) -> OC strengthened.
- bisphosphonate - OC inhibitor
- Denosumab (anti-RANKL)
- SERM - raloxifene -> anti-resorption - 약함
- bisphosphonate - 악골 괴사
- fatty acid-sensing GPCRs as therapeutic targets - GPR120 (receptor) - endogenous ligand - DHA, EPA 
- GPR120 and diabetes
- OC development (MQ is a precursor) - MQ proliferation -> Differentiation -> fusion -> polarization -> resorption
- Characteristics - Ruffled border. Polarization - **cytoskeletal organization** - actin cluster and **ring formation**
- GPR120 - upregulated during OC differentiation 
- GPR120 signaling enhances apoptosis in mature OC. - 파골세포가 죽는다.
- M-CSF-induced ring formation can be inhibited by GPR120.
- in vivo research? - Jung-Min Koh (Asan Medical Center)
- Beneficial effect of FFA4 on bone mass in an ovariectomized model.


### Strategy for Anti-Cancer Target 신영기 (서울약대)

### 재발자궁경부암 항암화학방사선 온열동시치료 이선영 (전북대학교병원)

Drug development I 김훈교
(가톨릭대학교 의과대학)
15:00~15:25
Non-clinical considerations for FIH 김봉태
(CJ)
15:25~15:50
임상약리학 주도 환자 대상 초기임상시험의 경험과 전망 이형기
(서울대학교병원)
15:50~16:15
The Contribution of Clinical Pharmacologist in Global Drug Development: Real Examples from a Big Pharma 김용호
(Parexel)
16:15~16:25 coffee & poster 
Drug development II 신상구 (차바이오컴플렉스)
16:25~16:50
BA/BE 임상시험 결과분석 시 고려사항: 분산투여 vs 추가시험 김정렬
(삼성서울병원)
16:50~17:15
The use of pharmacometrics for drug development in Korea 한승훈
(가톨릭의대)
17:15~17:40
Fatal BIA 10-2474 Phase I Clinical Trial : What Can We Learn? 임경수
(차의과대학 분당차병원)
17:40~18:00
우촌상 시상식 장인진 총무이사
18:00~
reception 
Time Lecture Speaker
학술대회
18일(금)  Will big data and data science reshape the horizon of drug development?, If so, how? 
Chair : Hiroshi Watanabe(president of JSCPT). Tae Sun Park(Chonbuk National University)
09:00~09:20
대규모 약물 유도 전사체 정보 기반 항암 신약 재창출 Wan Kyu Kim
Ewha Womans University
09:20~09:40
Big data platform for multi-national data collaboration Rae Woong Park
(Ajou University School
of Medicine)
09:40~10:00
TBD Yoshinori Ochiai
(Pharmaceuticals and
Medical Devices Agency)
10:00~10:20
How big data (national registry data) can be a game changer ? Hiroshi Ohtsu
(National Center for
Global Health and Medicine)
10:20~10:30
Q & A 
10:30~10:45 coffee break 
How can clinical pharmacology facilitate collaboration between the drug development industry and academia, particularly in the Asian-Pacific region? 
Chair : Kazutaka Shimoda(Dokkyo Medical University), Yil-Seob Lee(GSK)
10:45~11:05
Collaboration with Clinical Pharmacology in New Drug Development : Oncologist's View Do-Youn Oh
(Seoul National University
College of Medicine)
11:05~11:25
Drug development by connecting academy to venture company JungWon Woo 
(Genexine)
11:25~11:45
Examples of collaborations with local government and academia for Global FIH studies in Japan Masako Nakano
(Eli Lilly Japan K.K.)
11:45~12:05
Strategy for efficient drug development utilizing functions of ARO Yuji Kumagai
(Kitasato University)
12:05~12:15
Q & A 
12:15~13:30 점 심 시 간 
IT : CDISC DM ICT 남문석
(인하대학교 의과대학)
13:30~13:55
Case Report Form using Acrobat PDF 배균섭
(울산대학교 의과대학)
13:55~14:20
Big Data 소개 및 주의점 임지연
(동국대학교 의과대학)
14:20~14:45
Mobile App in clinical Trial 김민걸
(전북대학교 의과대학)
14:45~15:10
IT 활용 임상시험 효율화 이승환
(서울대학교 의과대학)
15:10~15:30 coffee break 
15:30~16:00
Young Scientist (8명) 
16:00~16:30 
16:30~17:00 
